• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES TOTAL BILIRUBIN; DIAZO COLORIMETRY, BILIRUBIN Back to Search Results
Model Number 6L45-21
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/27/2020
Event Type  malfunction  
Manufacturer Narrative
A review of tickets determined that there is normal complaint activity for architect total bilirubin reagent ln 6l45-21/lot number 56889uq02.Return testing was not completed as returns were not available.The tracking and trending review determined no trends were identified for discrepant patient results for the product.Worldwide data was reviewed and determined that the patient median result for total bilirubin reagent lot number 56889uq02 is within established control limits.Retesting of the samples gave expected normal results.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue was adequately addressed.Based on the investigation, no systemic issue or deficiency of the architect total bilirubin reagent lot number 56889uq02 was identified.
 
Event Description
The customer reported false decreased total bilirubin results for 2 patient samples while running on the architect c8000 processing module.The following data was provided on (b)(6) 2020 (reference range: 0.2-1.2 mg/dl): sample 1 = initial = 0.13 mg/dl; repeat result = 0.74 mg/dl.Sample 2 = initial = <0.10 mg/dl; repeat result = 0.94 mg/dl there was no impact to patient management reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL BILIRUBIN
Type of Device
DIAZO COLORIMETRY, BILIRUBIN
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer Contact
christian lee
100 abbott park road
dept. 09b9, lc cp01-3
abbott park, IL 60064-3537
2246682940
MDR Report Key10838627
MDR Text Key230510681
Report Number3016438761-2020-00299
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740011369
UDI-Public00380740011369
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K121985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2021
Device Model Number6L45-21
Device Catalogue Number06L45-21
Device Lot Number56889UQ02
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/27/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/02/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-